Massetolide A Biosynthesis in Pseudomonas fluorescens.

Massetolide A Biosynthesis in Pseudomonas fluorescens. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Massetolide A Biosynthesis in Pseudomonas fluorescens. Abstract Text:

I de Bruijn,M J D de Kock,P de Waard,T A van Beek,J M Raaijmakers,I de Bruijn,M J D de Kock,P de Waard,T A van Beek,J M Raaijmakers,

Massetolide A is a cyclic lipopeptide (CLP) antibiotic produced by various Pseudomonas strains from diverse environments. Cloning, sequencing, site-directed mutagenesis, and complementation showed that massetolide A biosynthesis in P. fluorescens SS101 is governed by three nonribosomal peptide synthetase (NRPS) genes, designated massA, massB, and massC, spanning approximately 30 kb. Prediction of the nature and configuration of the amino acids by in silico analysis of adenylation and condensation domains of the NRPSs was consistent with the chemically determined structure of the peptide moiety of massetolide A. Structural analysis of massetolide A derivatives produced by SS101 indicated that most of the variations in the peptide moiety occur at amino acid positions 4 and 9. Regions flanking the mass genes contained several genes found in other Pseudomonas CLP biosynthesis clusters, which encode LuxR-type transcriptional regulators, ABC transporters, and an RND-like outer membrane protein. In contrast to most Pseudomonas CLP gene clusters known to date, the mass genes are not physically linked but are organized in two separate clusters, with massA disconnected from massB and massC. Quantitative real-time PCR analysis indicated that transcription of massC is strongly reduced when massB is mutated, suggesting that these two genes function in an operon, whereas transcription of massA is independent of massBC and vice versa. Massetolide A is produced in the early exponential growth phase, and biosynthesis appears not to be regulated by N-acylhomoserine lactone-based quorum sensing. Massetolide A production is essential in swarming motility of P. fluorescens SS101 and plays an important role in biofilm formation.

Massetolide A Biosynthesis in Pseudomonas fluorescens. Publishing Authors By Initials

I de Bruijn,MJ de Kock,P de Waard,TA van Beek,JM Raaijmakers,I de Bruijn,MJ de Kock,P de Waard,TA van Beek,JM Raaijmakers,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Massetolide A Biosynthesis in Pseudomonas fluorescens. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of bacteriology

VOLUME: 190

Page Numbers: 2777-89

Journal Abbreviation:

ISSN: 1098-5530

DAY: 9

MONTH: 11

YEAR: 2007

Massetolide A Biosynthesis in Pseudomonas fluorescens. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985120

Massetolide A Biosynthesis in Pseudomonas fluorescens. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Massetolide A Biosynthesis in Pseudomonas fluorescens. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Massetolide A Biosynthesis in Pseudomonas fluorescens.

AFFILIATION: Laboratory of Phytopathology, Binnenhaven 5, 6709 PD Wageningen, The Netherlands. jos.raaijmakers@wur.nl.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Bacteriol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Massetolide A Biosynthesis in Pseudomonas fluorescens Related Publications

• Changes in beta-adrenergic responses as a consequence of infection with micro-organisms.
• Characterization of the topography of vacuum-deposited films. 1: Light scattering.
• Diversity and activity of biosurfactant-producing Pseudomonas in the rhizosphere of black pepper in Vietnam.
• Diversity of Cultivated Endophytic Bacteria from Sugarcane: Genetic and Biochemical Characterization of Burkholderia cepacia Complex Isolates.
• Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.
• Involvement of the ABC transporter BcAtrB and the laccase BcLCC2 in defence of Botrytis cinerea against the broad-spectrum antibiotic 2,4-diacetylphloroglucinol.
• Massetolide A Biosynthesis in Pseudomonas fluorescens.
• Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.
• [Saliva and intensity modulated radiotherapy]